InvestorsHub Logo
Followers 83
Posts 37897
Boards Moderated 0
Alias Born 05/09/2017

Re: None

Monday, 05/29/2017 11:46:48 AM

Monday, May 29, 2017 11:46:48 AM

Post# of 107737
How many big tech companies are willing to take the risk in developing a product in the cannabis market? Is it because they know MYDX is already doing it and are cash flow positive already?
How many big pharma companies are developing a medicinal marijuana vape pen that communicates to a device that can be used by doctors to prescribe remedies for their patients? Is it because they already know MYDX is doing it and is planning on releasing the product to the market by end of year? Are big pharma not taking the risk because they know they can just buy their way into MYDX and go through MYDX? How will all this affect current shareholders?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.